drugset / Trial / NCT02223026
Relative Bioavailability of a Linagliptin+Metformin Fixed Dose Combination Tablet Administered With and Without Food to Healthy Male and Female Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
Study to investigate the effect of food on the relative bioavailability of a 2.5 mg linagliptin+1000 mg metformin fixed dose combination (FDC) tablet
Timeline
- Start
- 2010-01
- Primary completion
- 2010-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Linagliptin | Unknown | 2.5 mg | — |
| Subject | Metformin | Small molecule | 1000 mg | — |
Indications
No indication recorded.